Federal Judge Dismisses AbbVie’s Challenge to Missouri’s 340B Contract Pharmacy Access Law for Lack of Standing

A federal district judge recently dismissed AbbVie's complaint against Missouri's 340B contract pharmacy access law for a lack of standing.
A federal district judge has dismissed AbbVie’s lawsuit challenging Missouri’s 340B contract pharmacy access law, marking another legal setback for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drugmakers File New Appeal Briefs in Push to Overturn 340B Rebate Ruling

Drugmakers filed new briefs in their pending 340B rebate cases before the D.C. Circuit Court of Appeals
Four large drugmakers recently filed a pair of new briefs in their ongoing appeals of legal rulings that upheld the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

PhRMA Sues Hawaii Over New 340B Contract Pharmacy Access Law

PhRMA sued to block Hawaii's new 340B contract pharmacy access law in a federal district court in Honolulu.
A major brand-name drug industry trade group has sued Hawaii over its new law prohibiting pharmaceutical manufacturers from restricting 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Organon, AbbVie Exempt New States From 340B Contract Pharmacy Restrictions

Organon announced 340B contract pharmacy restriction exemptions for covered entities in South Dakota, Hawaii, North Dakota and Colorado on July 14.
Two major drugmakers are exempting additional states from their 340B contract pharmacy restrictions due to new contract pharmacy access laws [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In High-Stakes Meetings, 340B Stakeholders Push to Sway HHS’ Rebate Guidance Ahead of Release

More than a dozen stakeholder groups haver recently met with federal officials about HHS' highly-anticipated 340B rebate guidance.
In a flurry of meetings with federal officials, drug industry and provider groups are making a final push to influence [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Five Drugmakers Exempt New States from 340B Contract Pharmacy Restrictions

AbbVie was among five drugmakers to announce new state exemptions to their 340B contract pharmacy restrictions in early July.
Five major drugmakers recently announced new contract pharmacy restriction exemptions for 340B covered entities located in South Dakota and other [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Updates in Tennessee and Utah

Key briefs were filed in litigation on contract pharmacy access laws in Tennessee and Utah.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Providers Slam Newly Enacted GOP Budget Law Over Deep Medicaid Cuts

President Donald Trump on July 4 signed a reconciliation bill with controversial Medicaid cuts that providers strongly criticized.
Provider groups are sharply criticizing the newly enacted, GOP-backed budget reconciliation bill, warning that its more than $1 trillion in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

California Senate Amends 340B Contract Pharmacy Access Bill to Add Provider Reporting, Audit Requirements

The California Senate Health Committee recently amended a 340B contract pharmacy access bill to add new audit and reporting requirements.
California state senators have amended new provider reporting and auditing requirements onto a bill barring drugmakers from placing 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Two Drugmakers Sue Oklahoma Over New 340B Contract Pharmacy Access Law

Drugmakers AbbVie and Novartis each filed federal lawsuits challenging Oklahoma's 340B contract pharamcy access law.
Two large drug companies this week filed federal lawsuits seeking to strike down Oklahoma’s new law prohibiting drugmaker 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live